Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds TD Cowen Initiates Coverage On Enliven Therapeutics with Outperform Rating

TD Cowen Initiates Coverage On Enliven Therapeutics with Outperform Rating

TD Cowen analyst Phil Nadeau initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Outperform rating.

byBenzinga Newsdesk

March 3, 2023

1 minute read

TD Cowen analyst Phil Nadeau initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Outperform rating.

Top 4 Tech Stocks That May Fall Off A Cliff

By Lisa Levin

April 28, 8:48 AM

The most overbought stocks in the information technology sector presents an opportunity to go short on these overvalued companies.

NATI

News
Tech

Microsoft’s Activision Blizzard Settles California Gender Discrimination Case For $55M

By Ananya Gairola

December 16, 1:10 AM

Activision Blizzard, now a Microsoft subsidiary, settles a sex discrimination case with the California Civil Rights Department for nearly $55 million, providing relief to affected women and addressing allegations of harassment and discrimination dating back to 2015.

ATVI

Analyst Ratings

Expert Ratings for Xylem

By Benzinga Insights

July 18, 4:53 PM

Within the last quarter, Xylem (NYSE:XYL) has observed the following analyst ratings:

XYL

Enbridge Raises Quarterly Dividend by 3.2% to C$0.8875

By Benzinga Newsdesk

February 10, 8:08 AM

Enbridge increased its 2023 quarterly dividend by 3.2% to $0.8875 ($3.55 annualized) per share, commencing with the dividend payable on March 1, 2023 to shareholders of record on February 15, 2023.

ENB

TD Cowen Initiates Coverage On Enliven Therapeutics with Outperform Rating

Related Posts

Top 4 Tech Stocks That May Fall Off A Cliff

Microsoft’s Activision Blizzard Settles California Gender Discrimination Case For $55M

Expert Ratings for Xylem

Enbridge Raises Quarterly Dividend by 3.2% to C$0.8875